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Aim To investigate the role of tumor apoptosis-inhibitory 
protein survivin in arsenic trioxide-induced apoptosis in 
VX-2 carcinoma in the rabbit liver by means of transcath-
eter arterial chemoembolization.
Methods Sixteen rabbits with 32 implanted hepatic VX-2 
tumors were randomly divided into two groups. The ex-
perimental group received 2 mg of arsenic trioxide and 
1 mL of ultra-fluid lipiodol co-injected via hepatic arterial 
cannulation and the control group received only 1 mL of 
lipiodol. Animals were sacrificed 3 weeks after trans-cath-
eterial arterial chemoembolization. Tumor tissue and tu-
mor-peripheral tissue were collected for analysis. Terminal 
deoxynucleotidyl transferase-mediated dUTP nick-end-la-
beling staining was used to assess tumor cells apoptosis. 
Immunohistochemistry was used to assess the presence 
of survivin protein. Reverse transcription polymerase chain 
reaction was used to determine the expression of survivin 
gene.
Results The number of apoptotic cells significantly in-
creased in the tumor tissue (5.20 ± 0.60%) compared to 
tumor-peripheral tissue (1.29 ± 0.42%) of the arsenic tri-
oxide-treated group. Survivin expression levels in the tu-
mor tissue were significantly reduced in arsenic trioxide-
treated group (7.68 ± 0.65) compared to the control group 
(35.30 ± 4.63).
Conclusion Transcatheter arterial chemoembolization 
with arsenic trioxide induced apoptosis of VX-2 carcinoma, 
in which tumor apoptosis-inhibitory protein survivin may 
have played a role.
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Hepatocellular carcinoma is the most common type of ma-
lignancy in Asia (1). Treatment of patients with unresectable 
hepatocellular carcinoma is conducted with transcatheter 
arterial chemoembolization (TACE) (2). Inhibition of apop-
tosis plays an important role in the generation of malig-
nant tumors, as well as their development and metastasis. 
Apoptosis is a physiological process important for the pres-
ervation of homeostasis and morphogenesis of tissues (3). 
Many chemotherapeutical drugs treat malignant tumors by 
interfering with pathological apoptosis regulation of tumor 
cells. Inducing apoptosis in tumor cells is also the opera-
tional principle of arsenic trioxide (ATO), an anticancer drug 
used in traditional medicine for many centuries (3,4).
Survivin has recently been identified as an inhibitor of 
apoptosis protein (IAP) (5) with still unclear pathophysi-
ological functioning. Survivin has a unique structure and 
is expressed in numerous human cancers and during em-
bryo development (6,7), but not in the adult differentiated 
tissues (8). Thus, survivin may serve as a new target for di-
agnosis and treatment of malignant tumors (9). The pres-
ent study investigated the involvement of survivin in ATO-
induced apoptosis.
MetHodS
tumor implantation in rabbit livers
VX-2 cell line originated from a papilloma transformed by 
the Shope papilloma virus. Active tumor tissues, obtained 
from rabbits inoculated with VX-2 tumors (VX-2 squamous 
carcinoma cell line), were implanted into the rabbit livers.
The tumor tissue was first washed with 0.9% NaCl solution, 
and divided into 1 mm pieces for implantation. The rabbits 
were anesthetized with intramuscular injection of sodium 
pentobarbital (30 mg/kg) and immobilized on a surgical table 
for stereotaxy. Following skin disinfection, a median incision 
was made below the xiphoid to expose the liver. A 1-2 mm 
deep cut was made in liver tissue with an ophthalmologic 
forceps and one prepared tumor tissue piece was implant-
ed. Two tumors were implanted in each rabbit. A single dose 
of intramuscular penicillin was used to prevent infection. Ex-
periments were carried out 3 weeks after tumor implanta-
tion, which is a period required for tumor cells growth.
experimental procedure and tissue sampling
Sixteen Japanese white rabbits (2000-2500 g; male: fe-
male = 1:1) were randomly divided into two groups using 
a table of random numbers (16 tumors each group). In the 
experimental group, 1 mL of ultra-fluid lipiodol (UFLP) with 
2 mg ATO (Sigma Chemical Co., St. Louis, MO, USA) was in-
jected into the hepatic artery, while the control group re-
ceived 1 mL UFLP.
Animals were sacrificed by an intravenous dose of sodium 
pentobarbital three weeks after the transcatheter arterial 
chemoembolization. Tumor tissue and tumor peripheral 
tissue within 2 cm of the tumor margin was collected. A 
part of the excised tissues was used for terminal deoxy-
nucleotidyl transferase-mediated dUTP nick-end-label-
ing (TUNEL) staining and immunohistochemical analysis, 
and the rest was used for reverse transcription polymerase 
chain reaction (RT-PCR). All experiments and surgical pro-
cedures were approved by the Institutional Animal Care 
and Use Committee at China Medical University, which 
complied with the National Institute of Health Guide for 
the Care and Use of Laboratory Animals, and all efforts 
were made to minimize animal suffering
detection of apoptotic cells
To investigate whether ATO-induced apoptosis, the dis-
tribution and number of TUNEL-positive cells were com-
pared between the experimental and control group. The 
excised tissues were fixed in 10% formalin for 24 hours, 
then embedded in paraffin, and sectioned into 3-μm 
thick sections using a sliding microtome. The slices were 
subjected to hematoxylin and eosin (HE) and TUNEL 
staining. For HE staining, the slices were stained with 
alum hematoxylin for 4-minute to visualize the nuclei, 
then washed with 0.3% acid alcohol and stained with eo-
sin for 2 minutes. DNA fragmentation was examined in 
tissue sections applying a modified TUNEL method (10) 
using an in situ Apoptosis Detection Kit (ApopTag; On-
cor, Gaithersburg, MD, USA). In brief, multiple fragment-
ed 3’-OH ends were labeled with digoxigenin-dUTP in 
the presence of terminal deoxynucleotidyl transferase. 
The slices were then counterstained with methylgreen. 
TUNEL-positive cells in the liver slices were counted us-
ing a conventional light microscope under a magnifi-
cation of 400. To determine the average frequencies of 
apoptotic cancer cells, 5 slides of each sample and 20 
microscopic fields were randomly selected and counted, 
and examined by three observers. The results were ex-
pressed as apoptotic index (AI), which was determined 
by the following formula: number of apoptotic cells/
number of the cells observed ×100%. Brown nucleus 
was assessed as a positive apoptotic cell.
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Immunohistochemistry
To assess changes in the survivin levels, we used immu-
nohistochemistry.. The slices were deparaffinized in xylene 
and rehydrated with gradual ethanol to water. To expose 
antigen epitopes, the slices were heated in a sodium cit-
rate buffer (pH 6.0) in a microwave at a power of 750W 
for 3.5 minutes. Treated slices were stored at room tem-
perature for 30 minutes and washed in phosphate-buff-
ered saline (PBS, pH 7.4). After preincubation in metha-
nol with 3% H2O2 for 20 minutes, slices were blocked by 
serum-free blocking solution at room temperature for 10 
minutes (Dako, Carpinteria, CA, USA) and incubated with 
anti-survivin monoclonal antibody (ab-1 clone 8 E2, Neo-
markers, Westinghouse, CA, USA) at a 1:200 dilution at 4°C 
overnight. After washing in PBS, the slices were incubat-
ed with biotinylated rabbit anti-mouse immunoglobulin 
(Dako-patts, Glostrup, Denmark) at a 1:200 dilution for 30 
minutes, followed by peroxidase-conjugated streptavidine 
(Dako-patts) at a 1:300 dilution for 30 minutes. Finally, they 
were subjected to 3, 30-diaminobenzidine and counter-
stained by hematoxylin.
Gene expression analysis by Rt-PCR
To further confirm survivin expression in rabbit liver tumor, 
we verified protein expression with complementary tech-
niques. The homogenate of the tumor tissue and tumor 
peripheral tissue were both used for RT-PCR. Total RNA was 
isolated using Trizol method according to the manufac-
turer’s instructions (Invitrogen, Carlsbad, CA, USA). The se-
quence of the forward primer for survivin was 5’-GAC CAC 
CGC ATC TCT ACA TTC AAG A-3’ and of the reverse prim-
er 5’-TGA AGC AGA AGA AAC ACT GGG C-3’; and the se-
quence of the forward primer for glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH) was 5’-TTA GCA CCC CTG 
GCC AAG G-3’ and of the reverse primer 5’-CTT ACT CCT 
TGG AGG CCA TG-3’. GAPDH was used as the internal refer-
ence. RT-PCR was performed according to the manufac-
turer’s protocol (Invitrogen). Reaction products were sepa-
rated on a 2% agarose gel with survivin detected at 139 
bp and GAPDH at 200 bp. Gels were photographed and 
integrated density values (IDV) were calculated by a Chemi 
Imager 5500 V2.03 software (AlPha InnCh, Miami, FL, USA).
Statistical analysis
All the experiments were repeated in triplicate and the 
data were presented as mean ± standard deviation 
(SD). Statistical analysis was condcuted with SPSS 
software, version 12.0 (SPSS Inc., Chicago, IL, USA). The ana-
lysts were blind to the treatment of each group. P < 0.05 
was considered statistically significant. To verify consistent 
mRNA loading among the gels, some blots were probed 
FIGuRe 1. Apoptosis of hepatocarcinoma cells induced by 
arsenic trioxide (Ato). (A) Representative microphotographs 
of terminal deoxynucleotidyl transferase-mediated dutP nick-
end-labeling (tuNeL) staining performed on liver tissue slices. 
tuNeL staining of apoptotic VX-2 carcinoma cells showed 
brown stained nuclei in irregular dotted form of various sizes. 
the arrowhead indicates representative apoptotic cells. A few 
apoptotic cells were found in the (a), (b), and (c), (a). tumor-
peripheral tissue in the control group (Group C). (b) tumor-pe-
ripheral tissue in the experimental group (Group e). (c) tumor 
tissue in the control group (Group C). (d) tumor tissue in the 
experimental group (Group e). Scale bar = 20 μm. (B) the bar 
graphs show the results of apoptotic index in tumor-peripher-
al and tumor tissues for (Aa), (Ab), (Ac), and (Ad), respectively. 
the height of each bar represents the mean ± standard devia-
tion. Least-significant difference test was used for multiple 
comparisons (n = 8).
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for GAPDH and the ratio with survivin was determined. 
There was no significant difference between the density 
percent control and the ratio with GAPDH; therefore, the 
analyses for the percent control are presented for each 
blot. The comparisons of the apoptotic index (AI) and sur-
vivin expression between tumor-peripheral and tumor tis-
sues in experimental and control groups were made using 
one-way ANOVA. When the F-value indicated significance, 
least-significant difference (LSD) or Tamhane’s T2 post hoc 
comparisons were made as appropriate to correct for mul-
tiple comparisons. All P-values were two-tailed.
ReSuLtS
Apoptosis of VX-2 carcinoma cells induced by Ato
In the ATO-treated group, significantly more apoptotic 
cells were observed in tumor tissue than in tumor-periph-
eral tissue, while in the control group fewer apoptotic cells 
were found in tumor than tumor-peripheral tissues (Figure 
1A). In ATO-treated group, the AI of the tumor tissue was 
significantly higher than that of the tumor-peripheral tis-
sue (Figure 1 B; P < 0.01), and the AI of the tumor tissue in 
the experimental group was significantly higher than that 
in the control group (Figure 1 B; P < 0.01).
down-regulation of survivin expression by Ato in liver 
tumor
Immunohistochemistry of paraffin-embedded samples re-
vealed a strong expression of survivin protein in tumor tis-
sue in the control group (Figure 2A) and weak expression 
in the experimental group (Figure 2A). In tumor-peripheral 
tissue, weak staining was found in both the experimental 
and control group. In addition, RT-PCR showed that the ex-
pression level of survivin mRNA in tumor tissue was sig-
nificantly lower in experimental than in the control group 
(Figure 2B and 2C; P < 0.01), indicating that the expression 
of survivin in tumor tissue was down-regulated by ATO. 
Moreover, the expression level of survivin mRNA was sig-
nificantly lower in tumor-peripheral tissue than in tumor 
tissue in both the control and experimental group (Figure 
2B and 2C; all P < 0.01)
dISCuSSIoN
The results showed that in VX-2 carcinoma tissue in the 
ATO group apoptosis was significantly increased and sur-
vivin mRNA and protein expression significantly reduced. 
This indicates that ATO may induce apoptosis in hepato-
cellular carcinoma cells, via survivin as the regulatory fac-
tor.
Suppression of apoptosis is important for carcinogenesis 
and tumor growth. Survivin, identified as a new apopto-
sis inhibitor in the IAP family, plays an important role in 
gene regulation (11,12). Unlike other members of the 
IAP family, survivin increases proliferation and decreas-
es apoptosis, which eventually leads to occurrence 
FIGuRe 2. down-regulation of survivin expression by arsenic 
trioxide (Ato). (A) Representative photomicrographs of im-
munohistochemical staining detected on liver tissue slices. 
the arrowhead indicates the representative positive cells. (a) 
CtP – tumor-peripheral tissue in the control group (Group C); 
(b) etP – tumor-peripheral tissue in the experimental group 
(Group e); (c) Ctt – tumor tissue in the control group (Group C); 
(d) ett – tumor tissue in the experimental group (Group e). Ato 
down-regulated the presence of survivin in the tumor tissue of 
the experimental group (d). Scale bar = 10 μm. (B) expression 
of survivin mRNA levels was determined by reverse transcrip-
tion polymerase chain reaction. Survivin transcription in CtP, 
etP, Ctt, and ett. Glyceraldehyde-3-phosphate dehydrogenase 
was used as an internal control. (C) the integrated density 
values of survivin mRNA levels were calculated and tamhane’s 
t2 test was used for multiple comparisons (n = 8). the height of 
each bar represents the mean ± standard deviation.
BASIC SCIENCE16 Croat Med J. 2013;54:12-6
www.cmj.hr
and growth of tumor (13). It was reported that survivin 
inhibits apoptosis of tumor cells, and consequently ac-
celerates their proliferative activity (12). Furthermore, the 
tumor-free 5-year survival rate of patients positive for sur-
vivin mRNA was significantly poorer than that of patients 
negative for survivin mRNA (12). In our study, survivin was 
much more abundant in VX-2 carcinoma cells than in tu-
mor-peripheral cells. This selective expression may be a 
self-protecting modification of VX-2 carcinoma cells, which 
stimulates efficient cell proliferation and tumor growth 
(14). After treatment with ATO, the expression level of sur-
vivin was reduced. Moreover, AI of tumor tissue was higher 
in the experimental than in the control group. Thus, we hy-
pothesize that survivin might be down-regulated by ATO 
through a pathway related to apoptosis in VX-2 carcinoma. 
A detailed mechanism is still unclear and deserves further 
investigation.
ATO applied through TACE could induce apoptosis, and 
survivin might play a role in ATO-induced apoptosis in VX-2 
carcinoma in the rabbit liver. Moreover, this study suggest-
ed that ATO treatment could be a novel and effective ther-
apeutic strategy for liver carcinoma.
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